Fastest Revenue Growth
Large-cap companies with the fastest year-over-year revenue growth.
As of Jul 28, 2026
| # | Company | Industry | Price | Mkt Cap | P/E | P/B | ROE | Net Margin | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JOBY | Aircraft | $7.37 | $7.25B | — | 3.70 | -47.5% | -1740.5% | 39183.1% | — |
| 2 | UEC | Miscellaneous Metal Ores | $9.91 | $4.90B | — | 3.45 | -6.2% | -131.1% | 29737.9% | — |
| 3 | VRDN | Pharmaceutical Preparations | $19.70 | $2.03B | — | 3.19 | -53.9% | -483.6% | 23359.9% | — |
| 4 | ARWR | Pharmaceutical Preparations | $85.53 | $12.05B | — | 19.62 | -0.3% | -0.2% | 23258.2% | — |
| 5 | QXO | INDUSTRIAL DISTRIBUTION | $14.13 | $10.25B | — | 1.01 | -2.7% | -4.1% | 11925.0% | — |
| 6 | IDYA | Biotechnology | $36.77 | $3.23B | — | 3.45 | -12.1% | -52.0% | 3024.4% | — |
| 7 | ASTS | Communications Services, NEC | $58.29 | $14.92B | — | 5.61 | -12.9% | -482.2% | 1505.2% | — |
| 8 | LQDA | DRUG MANUFACTURERS - SPECIALTY & GENERIC | $84.42 | $7.51B | — | 69.14 | -63.5% | -43.5% | 1031.2% | — |
| 9 | NUVB | Pharmaceutical Preparations | $6.66 | $2.32B | — | 7.26 | -64.0% | -325.3% | 699.0% | — |
| 10 | IBRX | Biological Products, (No Diagnostic Substances) | $6.99 | $7.32B | — | — | — | -310.2% | 668.3% | — |
| 11 | CRNX | Biotechnology | $83.85 | $8.84B | — | 6.90 | -36.3% | -6046.2% | 640.7% | — |
| 12 | ONDS | Radio & Tv Broadcasting & Communications Equipment | $8.02 | $3.98B | — | 3.70 | -12.3% | -260.7% | 605.3% | — |
| 13 | AHG | Software - Services | $1.46 | $2.42B | — | 12.19 | -68.1% | -913.4% | 512.1% | — |
| 14 | NBIS | Services-Computer Programming, Data Processing, Etc. | $187.88 | $47.54B | 576.20 | 10.35 | 1.8% | 15.6% | 479.0% | — |
| 15 | MDGL | Pharmaceutical Preparations | $551.25 | $12.71B | — | 23.39 | -53.0% | -30.1% | 432.1% | — |
| 16 | CYTK | BIOTECHNOLOGY | $80.62 | $10.03B | — | — | — | -891.6% | 376.6% | — |
| 17 | ARGX | Biological Products, (No Diagnostic Substances) | $888.82 | $55.00B | 42.57 | 7.51 | 17.6% | 3636.2% | 254.4% | — |
| 18 | ORLA | Gold and Silver Ores | $9.49 | $3.23B | 30.20 | 4.92 | 16.3% | 10.1% | 207.6% | 0.16% |
| 19 | IONQ | Services-Computer Integrated Systems Design | $35.92 | $13.41B | — | 2.69 | -10.3% | -392.6% | 201.9% | — |
| 20 | MESO | Biological Products, (No Diagnostic Substances) | $14.56 | $18.64B | — | 32.43 | -17.8% | -593.9% | 191.4% | — |
| 21 | EXE | OIL & GAS E&P | $90.51 | $21.65B | 11.90 | 1.11 | 9.3% | 15.0% | 186.3% | — |
| 22 | PGEN | BIOTECHNOLOGY | $5.64 | $2.01B | — | 99.37 | -1238.7% | -2588.2% | 146.7% | — |
| 23 | TARS | BIOTECHNOLOGY | $60.12 | $2.59B | — | 7.41 | -19.0% | -14.7% | 146.7% | — |
| 24 | AVAV | Aircraft | $154.24 | $7.81B | — | 1.77 | -6.0% | -13.4% | 140.9% | — |
| 25 | SNP.RO | Oil & Gas Integrated | $1.24 | $76.09B | 7.39 | 1.88 | 25.4% | 16.8% | 135.8% | — |
Dated archive
Permanent snapshots of this list, frozen each day.